5AM Ventures IV, L.P. 4
4 · Aprea Therapeutics, Inc. · Filed Oct 7, 2020
Insider Transaction Report
Form 4
5AM Ventures IV, L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-10-05$25.30/sh−175,000$4,427,500→ 138,497 total(indirect: See footnotes)
Holdings
- 75,965(indirect: See footnotes)
Common Stock
- 1,823,192(indirect: See footnotes)
Common Stock
Footnotes (5)
- [F1]Shares are held directly by 5AM Opportunities I, L.P. ("Opportunities"), which is under common control with the 5AM IV Funds. The 5AM IV Funds and Opportunities expressly disclaim status as a "group" for purposes of this Form 4.
- [F2]5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of the shares of Common Stock held directly by Opportunities, except to the extent of its or his pecuniary interest therein.
- [F3]Shares are held directly by 5AM Ventures IV, L.P.
- [F4]5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Dr. Scott M. Rocklage and Mr. Schwab disclaims beneficial ownership of the shares of Common Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.
- [F5]Shares are held directly by 5AM Co-Investors IV, L.P.